We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

By LabMedica International staff writers
Posted on 15 Nov 2024

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. More...

Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology patients.

In a new study, scientists at the Institute of Science of Data and Artificial Intelligence (DATAI) at the University of Navarra (Pamplona, Spain) analyzed data from over 3,000 patients diagnosed with lung and bladder cancers. By employing machine learning models, the researchers discovered new genetic signatures unique to each stage of these cancers and created a system known as the "IFIT index" (Index of "Physical Immunity"). This system is aimed at personalizing therapies to enhance their effectiveness. The IFIT index measures a patient's immunological fitness, categorizing them based on their risk at various stages of the disease. This approach allows for predicting how well a patient will respond to treatment depending on the activity of their immune system in different stages of cancer treatment.

The research, published in the Journal for ImmunoTherapy of Cancer, is based on an analysis of the cancer immunity cycle (CIC), which looks at how immune system signals affect the success of immunotherapy. Using this framework and AI tools, the researchers identified specific patterns of cellular activity linked to the molecular stages of the disease and developed the IFIT index. This innovation highlights the potential of AI in advancing personalized medicine and offers new prospects in the fight against cancer. The team also indicated that this technique will continue to be refined through future collaborative studies involving other cancer types.

"Immunotherapy represents one of the most promising frontiers in the fight against cancer, and by using artificial intelligence models, we can further fine-tune treatments based on each patient's immune profile," said Rubén Armañanzas, leader of DATAI's laboratory Digital Medicine and one of the lead authors of the study.

 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Automated PCR System
OnePCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: A family of molecules could help diagnose and treat breast cancer (Photo courtesy of Shutterstock)

Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. Some proteoglycans appear to shield the body from cancer,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.